Lloyds (LLDTF) buys 672,123 shares; intends to cancel
Rhea-AI Filing Summary
Lloyds Banking Group purchased 672,123 ordinary shares on 1 October 2025 from Morgan Stanley & Co. International plc under its existing buyback programme. The highest price paid was 83.9200 pence, the lowest 82.8800 pence, and the volume-weighted average price was 83.4405 pence. The purchases were effected pursuant to instructions issued to the broker on 20 February 2025 and announced on 21 February 2025. The Company states it intends to cancel these shares. A full breakdown of individual trades is provided in a linked schedule.
Positive
- 672,123 ordinary shares purchased were disclosed with precise price details (highest 83.9200p, lowest 82.8800p, VWAP 83.4405p).
- The purchases form part of an existing buyback programme executed under instructions dated 20 February 2025.
- Company intends to cancel the purchased shares, which will reduce issued share capital if completed.
Negative
- None.
Insights
TL;DR: Routine buyback execution: 672,123 shares acquired at ~83.44p VWAP; intended cancellation reduces share count.
The announcement documents a single-day tranche of Lloyds Banking Group's ongoing share buyback programme executed by Morgan Stanley. The disclosed trade sizes and prices are explicit: 672,123 shares purchased at a highest price of 83.92p and VWAP 83.4405p. These purchases were made under instructions dated 20 February 2025. The company states its intention to cancel the acquired shares, which, if completed, will reduce the issued share count. This disclosure is procedural and conforms to Market Abuse Regulation trade reporting requirements; it does not include financial statement impacts or the overall programme size in this filing.
TL;DR: Compliance-focused disclosure: trade-level reporting provided and cancellation intention stated; no governance concerns raised.
The filing supplies the required transaction disclosure and points to a schedule with a full breakdown of individual trades, meeting regulatory transparency obligations. The registrant confirms the buyback forms part of an existing programme instructed on 20 February 2025. The statement that the Company intends to cancel the shares is explicit, but the filing does not detail timing or the effect on authorized/issued share capital. From a governance perspective, the filing is succinct and regulatory-compliant but lacks additional context such as cumulative buyback progress or board rationale.
